In a report released yesterday, Stephen Baxter from Wells Fargo maintained a Hold rating on Cardinal Health (CAH – Research Report), with a ...

Morgan Stanley analyst Erin Wright maintained a Buy rating on Cardinal Health (CAH – Research Report) today and set a price target of $136.00.

Cardinal Health, Inc. CAH is scheduled to report fiscal second-quarter 2025 results on Jan. 30, before the opening bell. In ...

Stocks to Buy or Sell. In this article, we are going to take a look at where Cardinal Health, Inc. (NYSE:CAH) stands against ...

In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe ...

About Cardinal Health Cardinal Health is a distributor of pharmaceuticals and specialty products; a global manufacturer and distributor of medical and laboratory products; a supplier of home ...

Cardinal Health prepares to enter ... at-home healthcare supply business from the former medical segment, renamed Global Medical Products and Distribution; and the $1.2 billion unit manufacturing ...

The company said the new DC will support its at-Home Solutions business and improve the delivery of medical supplies to ...

Some readers see legalization as a matter of personal liberty, others see tax revenue. Still others see more impaired drivers on the road and kids getting easier access to weed.